Search research articles
Contact Us
Filters
Showing results (401-410 of 655) with videos related to
Page
of 66
Sort By:
British Journal of Cancer
|
July 4, 1998
Initial high anti-emetic efficacy of granisetron with dexamethasone is not maintained over repeated cycles
R de Wit, H van den Berg, J Burghouts, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 27, 2007
A multicentre phase I and pharmacokinetic study of BN80915 (diflomotecan) administered daily as a 20-min intravenous infusion for 5 days every 3 weeks to patients with advanced solid tumours
L Scott, O Soepenberg, J Verweij, et al.
Annals of Tropical Medicine and Parasitology
|
August 22, 2009
Detection of Clonorchis sinensis in stool samples using real-time PCR
E-M Kim, J J Verweij, A Jalili, et al.
The Journal of Eukaryotic Microbiology
|
July 16, 2009
Characterization of genotypes of Enterocytozoon bieneusi in immunosuppressed and immunocompetent patient groups
Robert J ten Hove, Lisette Van Lieshout, Mike B J Beadsworth, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1990
Ifosfamide plus doxorubicin in previously untreated patients with advanced soft tissue sarcoma. The EORTC Soft Tissue and Bone Sarcoma Group
J Schütte, H T Mouridsen, W Stewart, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
March 10, 2015
Prevalence of phylogroups and O25/ST131 in susceptible and extended-spectrum β-lactamase-producing Escherichia coli isolates, the Netherlands
I T M A Overdevest, A M C Bergmans, J J Verweij, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 15, 2001
Modulation of irinotecan-induced diarrhea by cotreatment with neomycin in cancer patients
D F Kehrer, A Sparreboom, J Verweij, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 29, 2011
Phase I safety and pharmacokinetic study of SU-014813 in combination with docetaxel in patients with advanced solid tumours
M J A de Jonge, H Dumez, J J E M Kitzen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 23, 2008
Lessons learned from independent central review
R Ford, L Schwartz, J Dancey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 8, 2014
Long-term responders and survivors on pazopanib for advanced soft tissue sarcomas: subanalysis of two European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62043 and 62072
B Kasper, S Sleijfer, S Litière, et al.
Page
of 66
Search research articles
Search
Showing results (401-410 of 655) with videos related to
Sort By:
Page
of 66
British Journal of Cancer
|
July 4, 1998
Initial high anti-emetic efficacy of granisetron with dexamethasone is not maintained over repeated cycles
R de Wit, H van den Berg, J Burghouts, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 27, 2007
A multicentre phase I and pharmacokinetic study of BN80915 (diflomotecan) administered daily as a 20-min intravenous infusion for 5 days every 3 weeks to patients with advanced solid tumours
L Scott, O Soepenberg, J Verweij, et al.
Annals of Tropical Medicine and Parasitology
|
August 22, 2009
Detection of Clonorchis sinensis in stool samples using real-time PCR
E-M Kim, J J Verweij, A Jalili, et al.
The Journal of Eukaryotic Microbiology
|
July 16, 2009
Characterization of genotypes of Enterocytozoon bieneusi in immunosuppressed and immunocompetent patient groups
Robert J ten Hove, Lisette Van Lieshout, Mike B J Beadsworth, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1990
Ifosfamide plus doxorubicin in previously untreated patients with advanced soft tissue sarcoma. The EORTC Soft Tissue and Bone Sarcoma Group
J Schütte, H T Mouridsen, W Stewart, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
March 10, 2015
Prevalence of phylogroups and O25/ST131 in susceptible and extended-spectrum β-lactamase-producing Escherichia coli isolates, the Netherlands
I T M A Overdevest, A M C Bergmans, J J Verweij, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 15, 2001
Modulation of irinotecan-induced diarrhea by cotreatment with neomycin in cancer patients
D F Kehrer, A Sparreboom, J Verweij, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 29, 2011
Phase I safety and pharmacokinetic study of SU-014813 in combination with docetaxel in patients with advanced solid tumours
M J A de Jonge, H Dumez, J J E M Kitzen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 23, 2008
Lessons learned from independent central review
R Ford, L Schwartz, J Dancey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 8, 2014
Long-term responders and survivors on pazopanib for advanced soft tissue sarcomas: subanalysis of two European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62043 and 62072
B Kasper, S Sleijfer, S Litière, et al.
Page
of 66